BIOMAT Database Logo BIOMAT Database Logo

Synthesis, in vitro antimalarial activities and cytotoxicities of amino-artemisinin-ferrocene derivatives. 2018

Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom 2520, South Africa.

Novel derivatives bearing a ferrocene attached via a piperazine linker to C-10 of the artemisinin nucleus were prepared from dihydroartemisinin and screened against chloroquine (CQ) sensitive NF54 and CQ resistant K1 and W2 strains of Plasmodium falciparum (Pf) parasites. The overall aim is to imprint oxidant (from the artemisinin) and redox (from the ferrocene) activities. In a preliminary assessment, these compounds were shown to possess activities in the low nM range with the most active being compound 6 with IC50 values of 2.79 nM against Pf K1 and 3.2 nM against Pf W2. Overall the resistance indices indicate that the compounds have a low potential for cross resistance. Cytotoxicities were determined with Hek293 human embryonic kidney cells and activities against proliferating cells were assessed against A375 human malignant melanoma cells. The selectivity indices of the amino-artemisinin ferrocene derivatives indicate there is overall an appreciably higher selectivity towards the malaria parasite than mammalian cells.

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005296 Ferrous Compounds Inorganic or organic compounds that contain divalent iron. Compounds, Ferrous
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075163 Metallocenes Organometallic compounds that generally consist of two cylcopentadiene ANIONS joined in their centers by a metallic cation such as NICKEL; IRON; or TITANIUM. Ferrocenes
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Synthesis and antimalarial activities of several fluorinated artemisinin derivatives.
September 1995, Journal of medicinal chemistry,
Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Synthesis and antimalarial activity of artemisinin derivatives containing an amino group.
April 2000, Journal of medicinal chemistry,
Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Synthesis and antimalarial activity of novel dihydro-artemisinin derivatives.
May 2011, Molecules (Basel, Switzerland),
Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Synthesis and antimalarial activity of some 9-substituted artemisinin derivatives.
August 1993, Journal of medicinal chemistry,
Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids.
March 2011, Bioorganic & medicinal chemistry letters,
Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Artemisinin derivatives bearing Mannich base group: synthesis and antimalarial activity.
October 2003, Bioorganic & medicinal chemistry,
Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX.
December 2000, Bioorganic & medicinal chemistry,
Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Synthesis, antimalarial activity and cytotoxicity of 10-aminoethylether derivatives of artemisinin.
August 2012, Bioorganic & medicinal chemistry,
Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
Synthesis, characterization and in vitro antiproliferative activities of new 13-cis-retinoyl ferrocene derivatives.
June 2009, European journal of medicinal chemistry,
Christo de Lange, and Dina Coertzen, and Frans J Smit, and Johannes F Wentzel, and Ho Ning Wong, and Lyn-Marie Birkholtz, and Richard K Haynes, and David D N'Da
In vitro antimalarial studies of novel artemisinin biotransformed products and its derivatives.
November 2014, Phytochemistry,
Copied contents to your clipboard!